» Articles » PMID: 18154816

Use of Video-assisted Thoracic Surgery for Lobectomy in the Elderly Results in Fewer Complications

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2007 Dec 25
PMID 18154816
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to determine if the utilization of video-assisted thoracic surgery (VATS) for lobectomy for clinical stage I non-small cell lung cancer in elderly patients results in decreased complications compared with lobectomy by thoracotomy (THOR).

Methods: A retrospective, matched case-control study was performed evaluating the perioperative outcomes after lobectomy by VATS versus THOR performed in elderly patients (age > or = 70 years) at a single institution. All complications were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0 (http://ctep.cancer.gov/reporting/ctc.html).

Results: Between May 1, 2002 and December 31, 2005 333 patients (245 THOR, 88 VATS) 70 years old or greater underwent lobectomy for clinical stage I non-small cell lung cancer. After matching based on age, gender, presence of comorbid conditions, and preoperative clinical stage, there were 82 patients in each group. Patients had similar preoperative characteristics. A VATS approach resulted in a significantly lower rate of complications compared with THOR (28% vs 45%, p = 0.04) and a shorter median length of stay (5 days, range 2 to 20 vs 6 days, range 2 to 27, p < 0.001). No patients undergoing VATS lobectomy had higher than grade 2 complications, whereas 7% of complications in the THOR group were grade 3 or higher. There were no perioperative deaths in the VATS patients compared with an in-hospital mortality rate of 3.6% (3 of 82) for THOR patients.

Conclusions: A VATS approach to lobectomy for clinical stage I non-small cell lung cancer in the elderly was associated with fewer and overall reduced severity of complications as well as a shorter hospital stay compared with thoracotomy.

Citing Articles

Predictors associated with Clavien-Dindo complications in lung cancer surgery: A retrospective cohort study.

Saetang M, Kunapaisal T, Wasinwong W, Boonthum P, Sriyanaluk B, Nuanjun K PLoS One. 2024; 19(12):e0316214.

PMID: 39739759 PMC: 11687775. DOI: 10.1371/journal.pone.0316214.


Ninjin'yoeito improves respiratory symptoms after lung cancer surgery: a prospective randomized study.

Mitsui S, Tanaka Y, Nishikubo M, Doi T, Tane S, Hokka D Surg Today. 2024; .

PMID: 39718597 DOI: 10.1007/s00595-024-02977-w.


Exploring Surgical Management Strategies for Endobronchial Tumors.

Thi C, Vinh V, Nhat L Cureus. 2024; 16(11):e73036.

PMID: 39502749 PMC: 11536497. DOI: 10.7759/cureus.73036.


Salivary metabolites as potential predictive biomarkers for lung surgery complications: a retrospective cross-sectional study.

Takamori S, Ishikawa S, Sato K, Watanabe H, Suzuki J, Oizumi H Surg Today. 2024; 54(8):866-873.

PMID: 38356076 DOI: 10.1007/s00595-024-02794-1.


Differential Outcomes of VATS and Open Surgery in Lung Cancer Patients with Antecedent Oncological Diagnoses.

Tanase B, Burlacu A, Nistor C, Horvat T, Oancea C, Marc M J Pers Med. 2023; 13(10).

PMID: 37888110 PMC: 10608346. DOI: 10.3390/jpm13101498.